Table 1 The patient characteristics and baseline lung function parameters for the 39 subjects in this study
Male/Female ratio, numbers (percentage) | 12/27 (31%/69%) |
Age, years | 66 ± 7 |
Smoker, (ex-/current)$ | 13/26 (33%/67%) |
GOLD stage 1 patients, number | 10 |
GOLD stage 2 patients, number | 29 |
FEV1, L/s (pre-bronchoconstriction) | 1.89 ± 0.46 |
FVC, L (pre-bronchoconstriction) | 3.11 ± 0.72 |
FEV1/FVC (%, pre-bronchoconstriction) | 61.1 ± 8.1 |
FEV1 (% predicted) | 67.0 ± 11.1 |
FEV1, L/s (post-bronchoconstriction) | 1.67 ± 0.49 |
FVC, L (post-bronchoconstriction) | 2.83 ± 0.73 |
FIV1, L/s | 2.92 ± 0.75 |
IC, L | 2.32 ± 0.53 |
FIF50, L/s | 4.97 ± 1.40 |
PIF, L/s | 5.40 ± 1.48 |
PD20, mg | 0.13 (0.04 to >2.60#) |